Simple case definition of clinical benign prostatic hyperplasia, based on international prostate symptom score, predicts general practitioner consultation rates

被引:10
作者
Kok, Esther T.
Bohnen, Arthur M.
Jonkheijm, Rikkert
Gouweloos, Jochem
Groeneveld, Frans P. M. J.
Thomas, Siep
Bosch, J. L. H. Ruud
机构
[1] Erasmus Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Urol, Utrecht, Netherlands
关键词
D O I
10.1016/j.urology.2006.04.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine which case definition of clinical benign prostatic hyperplasia (BPH) has the best predictive value for general practitioner visits for lower urinary tract symptoms (LUTS) suggestive of BPH. The incidence and prevalence rates of general practitioner visits for LUTS were also determined. Methods. A longitudinal, population-based study from 1995 to 2003 was conducted among 1688 men aged 50 to 78 years old. Data were collected on physical urologic parameters, quality of life, and symptom severity as determined from the International Prostate Symptom Score. Information on health-care-seeking behavior of all participants was collected from the general practitioner (GP) record using a computerized search engine and an additional manual check of the electronically selected files. Results. The incidence and prevalence rate of the men at risk was 19.6% and 14.0%, respectively, and these rates increased with age. For sensitivity and the positive predictive value, the case-definition of clinical BPH as an International Prostate Symptom Score greater than 7 had the best predictive value for GP visits for LUTS within 2 years after baseline. Conclusions. Because only marginal improvement (greater specificity but lower sensitivity) in the prediction of GP visits for LUTS was possible by adding information on prostate volume and flow, for the prediction of future GP visits for LUTS suggestive of BPH, we suggest that the International Prostate Symptom Score questionnaire be used and that estimation of the prostate volume and flow is not required. (c) 2006 Elsevier Inc.
引用
收藏
页码:784 / 789
页数:6
相关论文
共 13 条
[1]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[2]   Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status [J].
Blanker, MH ;
Groeneveld, FPMJ ;
Prins, A ;
Bernsen, RMD ;
Bohnen, AM ;
Bosch, JLHR .
BJU INTERNATIONAL, 2000, 85 (06) :665-671
[3]   Validity of three calliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: The krimpen study [J].
Bosch, JLHR ;
Bohnen, AM ;
Groeneveld, FP ;
Bernsen, R .
PROSTATE, 2005, 62 (04) :353-363
[4]  
BOSCH JLHR, 1995, UROLOGY, V46, P34
[5]  
CHATELAIN C, 2001, P 5 INT C BEN PROST, P112
[6]   How do symptoms indicative of BPH progress in real life practice? The UK experience [J].
Clifford, GM ;
Logie, J ;
Farmer, RDT .
EUROPEAN UROLOGY, 2000, 38 :48-53
[7]  
CunninghamBurley S, 1996, BRIT J GEN PRACT, V46, P349
[8]   HIGH PREVALENCE OF BENIGN PROSTATIC HYPERTROPHY IN THE COMMUNITY [J].
GARRAWAY, WM ;
COLLINS, GN ;
LEE, RJ .
LANCET, 1991, 338 (8765) :469-471
[9]  
KOK ET, 2006, IN PRESS EUR UROL
[10]   Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion [J].
Lowe, FC ;
Batista, J ;
Berges, R ;
Chartier-Kastler, E ;
Conti, G ;
Desgrandchamps, F ;
Dreikorn, K ;
O'Leary, M ;
Perez, M ;
Speakman, M ;
Trachtenberg, J ;
Tubaro, A ;
Meesen, B ;
Smets, L ;
Stoevelaar, H .
PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (03) :206-209